1 / 21

Welcome Duke Eye Center Alumni AAO 2011 – Orlando, Florida

Welcome Duke Eye Center Alumni AAO 2011 – Orlando, Florida. Eye Clinical Building Certificate of Need Filed in August 2011!. Eye Clinical Building Site – Campus Context. VA. Erwin Road. PG IX. Anlyan. MSRB. Duke Hospital North. Research Drive. Lab. Jones. Sands. Wadsworth Building.

zed
Download Presentation

Welcome Duke Eye Center Alumni AAO 2011 – Orlando, Florida

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Welcome Duke Eye Center Alumni AAO 2011 – Orlando, Florida

  2. Eye Clinical BuildingCertificate of Need Filed in August 2011!

  3. Eye Clinical BuildingSite – Campus Context VA Erwin Road PG IX Anlyan MSRB Duke Hospital North Research Drive Lab Jones Sands Wadsworth Building Albert Eye Research Institute Wadsworth Building

  4. Awards and Recognitions Research to Prevent Blindness (RPB) has awarded three distinct grants, totaling $190,000, to Duke Eye Center. A grant of $100,000 to the Department of Ophthalmology at Duke University School of Medicine will support research into the causes, treatment, and prevention of blinding eye diseases. RPB also awarded a $60,000 Physician-Scientist Award to Cynthia A. Toth, MD. Toth is one of 46 physician-scientists at 24 institutions who have received the award since it was established in 2000. Toth has identified macular edema in the retina of many premature infants with retinopathy of prematurity (ROP).She now wishes to study how this macular finding relates to the ROP disease process and the systemic health of premature infants. Her long-term goals are to identify whether this is a marker for a specific phase of ROP activity, and whether macular edema in infancy has an impact on vision development. A$30,000 RPB Medical Student Eye Research Fellowship will enable Wenlan Zhang to take a year off from medical school to pursue a research project within the Department of Ophthalmology. Zhang will conduct research with Dr. Catherine Bowes Rickman, studying genetic polymorphisms in age-related macular degeneration. This important RPB program will greatly augment Zhang’s research experience and prepare her for a successful career in academic ophthalmology.

  5. Duke Eye Center-Ranked #7 by US News and World Report Congratulations to the following faculty members named to US News’ 2011 List of Top Doctors— • Natalie Afhsari, MD • Rand Allingham, MD • Tariq Bhatti, MD • Ed Buckley, MD • Alan Carlson, MD • Sharon Freedman, MD • Terry Kim, MD • Paul Lee, MD, JD

  6. …and congratulations to the following faculty members also named to America’s Top Doctors Ed Buckley, MD Sharon Freedman, MD Paul Lee, MD, JD

  7. Welcome to Duke Eye Center’s New Faculty Anna Bordelon, MD Department/Division Comprehensive Ophthalmology TrainingMD, University of Virginia School of Medicine, 2003 ResidencyOphthalmology, Duke Eye Center, 2006-2009 FellowshipCornea, External Diseases and Refractive Surgery, Wilmer Eye Institute at Johns Hopkins (Maryland), 2009-2010 Clinical InterestsCataract surgery, corneal transplant surgery, intraocular lenses, ocular surface disorders, allergic eye disease, refractive surgery, general ocular disease and corneal disease

  8. Welcome to Duke Eye Center’s New Faculty Derek DelMonte, MD Department/Division Ophthalmology-General TrainingMD, University of Michigan Medical School, 2006 ResidencyInternal Medicine, Evanston Northwestern Healthcare (Illinois), 2006-2007 Ophthalmology, Duke Eye Center, 2007-2010 FellowshipCornea, External Disease, and Refractive Surgery, The Bascom Palmer Eye Institute, University of Miami Miller School of Medicine (Florida), 2011 Clinical InterestsCorneal transplantation; cataract surgery using astigmatism- and presbyopia-correcting intraocular lenses; laser refractive vision correction; research in new therapies for corneal ectasia (thinning) and infectious keratitis

  9. Welcome to Duke Eye Center’s New Faculty Preeya Gupta, MD Department / DivisionOphthalmology / Corneal Ophthalmology TrainingMD, Northwestern University Feinberg School of Medicine (Illinois), 2006 ResidencyOphthalmology, Duke Eye Center, 2010 FellowshipCornea and Refractive Surgery, Minnesota Eye Consultants, Phillips Eye Institute, 2011 Clinical InterestsCorneal transplantation (PK, DSEK); refractive surgery (PRK, PTK, custom LASIK); femtosecond laser; phakic intraocular lens (implantable collamer lens, Visian ICL); cataract surgery; presbyopia- and astigmatism-correcting intraocular lenses Research InterestsDry eyes; Blepharitis; Keratoconus; LASIK surgery; DSEK; OCT

  10. Welcome to Duke Eye Center’s New Faculty Tamer Mahmoud, MD, PhD Department / DivisionOphthalmology / Retinal Ophthalmology TrainingMD, Ain-Shams University, 1992 ResidencySurgery, Duke University Medical Center, 1999-2000 Ophthalmology, Duke Eye Center, 2000-2003 FellowshipRetina, Clinical and Basic Research, Duke Eye Center, 1997-1999 Vitreoretinal Surgery, Duke Eye Center, 2003-2005 Clinical InterestsDiagnose and treat retinal diseases with special interest in diabetic retinopathy, macular degeneration, retinal vascular diseases, complex retinal detachment, small gauge vitrectomy, and long-acting intraocular implants Research InterestsDr. Mahmoud specializes in Diabetic Retinopathy, Angiogenesis, Retinal Vascular Occlusion, Retinal Surgery Instrument Development, Macular degeneration, Retinal Detachment with Proliferative Vitreoretinopathy, retinal Imaging, Retinal Implants, Macular Edema, Intraocular Injections, Macular Holes, and Epiretinal Membranes.  Dr. Mahmoud was the program director of the Vitreoretinal Surgery Fellowship at the Kresge Eye Institute in Michigan before coming back to Duke to join the retina faculty.

  11. Welcome to Duke Eye Center’s New Faculty S. Grace Prakalapakorn, MD Department / DivisionOphthalmology / Pediatric Ophthalmology TrainingMD, Emory University School of Medicine (Georgia), 2005 ResidencyTransitional Internship, Scripps Mercy Hospital (California), 2005-2006 Ophthalmology, Emory University Hospital (Georgia), 2006-2009 FellowshipPediatric Ophthalmology and Strabismus, Duke Eye Center, 2010-2011 Other TrainingMPH, Emory University School of Public Health, 2005 Clinical InterestsMedical and surgical management of pediatric eye disorders and adult/childhood strabismus; congenital/pediatric cataracts; intraocular lens implants; amblyopia; diplopia; ocular motility disorders; nasolacrimal duct obstruction; screening and treatment of retinopathy of prematurity.

  12. Welcome to Duke Eye Center’s New Faculty Jullia Rosdhal, MD, PhD Department / DivisionOphthalmology / Glaucoma Ophthalmology TrainingMD, Case Western Reserve University School of Medicine (Ohio), 2004 ResidencyPreliminary Year, Internal Medicine, Caritas Carney Hospital, Tufts University (Massachusetts), 2004-2005 Ophthalmology, Massachusetts Eye and Ear Infirmary, Harvard University, 2007-2010 FellowshipGlaucoma, Duke Eye Center, 2010-2011 Other TrainingPhD, Case Western Reserve University School of Medicine (Ohio), 2002 Clinical InterestsDiagnosis and treatment of glaucoma, cataracts, and general diseases; glaucoma laser, incisional surgical therapies, cataract surgery

  13. Welcome to Duke Eye Center’s New Faculty W. Daniel Stamer, PhD  The Pathobiology of Ocular Hypertension in Glaucoma My laboratory studies the disease of glaucoma, the second leading cause of blindness in the United States, affecting nearly 3 million people (70 million Worldwide). The primary risk factor for developing glaucoma is ocular hypertension (high intraocular pressure, IOP). IOP is a function of aqueous humor moving into and out of the eye.  Elevated IOP in glaucoma is a result of disease in the primary efflux route, the conventional outflow pathway, affecting proper drainage of aqueous humor. Controlling IOP in glaucoma patients, whether or not they have ocular hypertension, is important because large clinical trials involving tens of thousands of patients repeatedly demonstrate that significant, sustained IOP reduction slows or halts vision loss. Unfortunately, current daily medical treatments do not target the diseased conventional pathway and do not lower IOP sufficiently in most people with glaucoma. Therefore, finding new, more effective ways to medically control IOP by targeting the conventional pathway is a central goal the Stamer Laboratory. Using molecular, cellular and organ-based model systems, my laboratory seeks to identify and validate novel drug targets in the human conventional outflow pathway such that novel treatment of ocular hypertension and glaucoma can be developed.

  14. Keep In Touch Online! • dukeeye.org • dukeeyecenter.duke.edu • Facebook.com/dukeeye

  15. Keep In Touch Online! • dukeeye.org • dukeeyecenter.duke.edu • Facebook.com/dukeeye

More Related